Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients

Nourhan M El Samaloty1, Zeinab A Hassan2, Zeinab M Hefny3

  • 1Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Future University, Egypt.

Abstract

Insights

Hepatitis C virus (HCV) infection is linked to insulin resistance (IR) and type 2 diabetes (T2D). This study found higher miR-155 levels in HCV patients, which decreased with diabetes and correlated with IR markers.

Area of Science:

  • Hepatology
  • Endocrinology
  • Molecular Biology

Background:

  • Chronic Hepatitis C virus (HCV) infection poses a global health challenge.
  • Insulin resistance (IR) and type 2 diabetes (T2D) are significant metabolic complications associated with chronic HCV.
  • MicroRNAs (miRNAs) are key regulators of biological processes, including metabolic functions.

Purpose of the Study:

  • To investigate serum levels of miR-155 and miR-34a in chronic HCV patients.
  • To compare miRNA levels in HCV patients with and without type 2 diabetes (T2D).

Main Methods:

  • Quantitative real-time PCR was used to measure miR-155 and miR-34a expression.
  • The study included 80 participants: HCV patients, HCV/T2D patients, T2D patients, and healthy controls.

Main Results:

  • Both miR-155 and miR-34a were significantly elevated in chronic HCV patients compared to controls.
  • Circulating miR-155 levels were significantly lower in HCV patients with T2D compared to those without.
  • miR-155 levels showed an inverse correlation with HOMA-IR, fasting blood glucose, and HbA1c.

Conclusions:

  • miR-155 is strongly associated with insulin resistance and T2D in the context of HCV infection.
  • These findings suggest a potential role for miR-155 in the pathogenesis of HCV-induced IR.
  • Further large-scale studies are warranted to validate these results.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.8K
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.7K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
269